A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays (2020)
Fonte: Leukemia & Lymphoma. Unidades: FMRP, FCFRP, BIOINFORMÁTICA
Assuntos: NEOPLASIAS, MUTAÇÃO GENÉTICA, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOGNON, Raquel et al. A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays. Leukemia & Lymphoma, v. 61, n. 13, p. 3052-3065, 2020Tradução . . Disponível em: https://doi.org/10.1080/10428194.2020.1805110. Acesso em: 07 nov. 2024.APA
Tognon, R., Silva, D. C. de A. e, Rey, R. A., Ristov, M., Ambrósio, L., Almeida, F. C. de, et al. (2020). A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays. Leukemia & Lymphoma, 61( 13), 3052-3065. doi:10.1080/10428194.2020.1805110NLM
Tognon R, Silva DC de A e, Rey RA, Ristov M, Ambrósio L, Almeida FC de, Nunes N de S, Souto EX, Perobelli L de L, Simões BP, Guthy DA, Radimerski T, Castro FA de. A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays [Internet]. Leukemia & Lymphoma. 2020 ; 61( 13): 3052-3065.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1080/10428194.2020.1805110Vancouver
Tognon R, Silva DC de A e, Rey RA, Ristov M, Ambrósio L, Almeida FC de, Nunes N de S, Souto EX, Perobelli L de L, Simões BP, Guthy DA, Radimerski T, Castro FA de. A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays [Internet]. Leukemia & Lymphoma. 2020 ; 61( 13): 3052-3065.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1080/10428194.2020.1805110